| Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction E González-López, M Gallego-Delgado, G Guzzo-Merello, ... European heart journal 36 (38), 2585-2594, 2015 | 1013 | 2015 |
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 636 | 2020 |
| Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European heart journal 42 (16), 1554-1568, 2021 | 609 | 2021 |
| Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies MF Ortiz-Genga, S Cuenca, M Dal Ferro, E Zorio, R Salgado-Aranda, ... Journal of the American College of Cardiology 68 (22), 2440-2451, 2016 | 415 | 2016 |
| Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy G Luxán, JC Casanova, B Martínez-Poveda, B Prados, G D'amato, ... Nature medicine 19 (2), 193-201, 2013 | 345 | 2013 |
| Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths E González-López, C Gagliardi, F Dominguez, CC Quarta, ... European heart journal 38 (24), 1895-1904, 2017 | 340 | 2017 |
| Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria G Quarta, A Muir, A Pantazis, P Syrris, K Gehmlich, P Garcia-Pavia, ... Circulation 123 (23), 2701-2709, 2011 | 285 | 2011 |
| 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) E Arbelo, A Protonotarios, JR Gimeno, E Arbustini, R Barriales-Villa, ... European heart journal 44 (37), 3503-3626, 2023 | 284 | 2023 |
| Screening for transthyretin amyloid cardiomyopathy in everyday practice RM Witteles, S Bokhari, T Damy, PM Elliott, RH Falk, NM Fine, ... JACC: Heart Failure 7 (8), 709-716, 2019 | 277 | 2019 |
| Genetic variants associated with cancer therapy–induced cardiomyopathy P Garcia-Pavia, Y Kim, MA Restrepo-Cordoba, IG Lunde, H Wakimoto, ... Circulation 140 (1), 31-41, 2019 | 237 | 2019 |
| Genetic etiology for alcohol-induced cardiac toxicity JS Ware, A Amor-Salamanca, U Tayal, R Govind, I Serrano, ... Journal of the American College of Cardiology 71 (20), 2293-2302, 2018 | 234 | 2018 |
| Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases P Garcia‐Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European journal of heart failure 23 (4), 512-526, 2021 | 224 | 2021 |
| Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy F Dominguez, U Kühl, B Pieske, P Garcia-Pavia, C Tschöpe Revista Española de Cardiología (English Edition) 69 (2), 178-187, 2016 | 223 | 2016 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 222 | 2019 |
| Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial … ALP Caforio, Y Adler, C Agostini, Y Allanore, A Anastasakis, M Arad, ... European heart journal 38 (35), 2649-2662, 2017 | 213 | 2017 |
| RADIAL: a novel primary graft failure risk score in heart transplantation J Segovia, MDG Cosío, JM Barceló, MG Bueno, PG Pavía, R Burgos, ... The Journal of heart and lung transplantation 30 (6), 644-651, 2011 | 213 | 2011 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 201 | 2019 |
| Alcoholic cardiomyopathy G Guzzo-Merello, M Cobo-Marcos, M Gallego-Delgado, P Garcia-Pavia World journal of cardiology 6 (8), 771, 2014 | 198 | 2014 |
| Association of sleep duration and quality with subclinical atherosclerosis F Domínguez, V Fuster, JM Fernández-Alvira, L Fernández-Friera, ... Journal of the American College of Cardiology 73 (2), 134-144, 2019 | 183 | 2019 |
| International external validation study of the 2014 European Society of Cardiology guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy (EVIDENCE-HCM) C O’Mahony, F Jichi, SR Ommen, I Christiaans, E Arbustini, ... Circulation 137 (10), 1015-1023, 2018 | 177 | 2018 |
